Literature DB >> 33860906

Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Elizabeth R Wallace1, Suzanne C Segerstrom2, Craig G van Horne3,4, Frederick A Schmitt2,3, Lisa M Koehl5.   

Abstract

Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease (PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia (PDD). Mild cognitive impairment (MCI) has been identified as a transitional state between normal cognition and dementia. Although PD-MCI and its cognitive correlates have been increasingly studied as a risk indicator for development of PDD, investigations into the PD-MCI construct have yielded heterogeneous findings. Thus, a typical PD-MCI cognitive profile remains undefined. The present meta-analysis examined published cross-sectional studies of PD-MCI and cognitively normal PD (PD-CN) groups to provide aggregated effect sizes of group test performance by cognitive domain. Subsequently, longitudinal studies examining PD-MCI to PDD progression were meta-analyzed. Ninety-two cross-sectional articles of PD-MCI vs. PD-CN were included; 5 longitudinal studies of PD-MCI conversion to PDD were included. Random effects meta-analytic models were constructed resulting in effect sizes (Hedges' g) for cognitive domains. Overall performance across all measures produced a large effect size (g = 0.83, 95% CI [0.79, 0.86], t2 = 0.18) in cross-sectional analyses, with cognitive screeners producing the largest effect (g = 1.09, 95% CI [1.00, 1.17], t2 = 0.19). Longitudinally, overall measures produced a moderate effect (g = 0.47, 95% CI [0.40, 0.53], t2 = 0.01), with measures of executive functioning exhibiting the largest effect (g = 0.70, 95% CI [0.51, 0.89], t2 = 0.01). Longitudinal effects were made more robust by low heterogeneity. This report provides the first comprehensive meta-analysis of PD-MCI cognitive outcomes and predictors in PD-MCI conversion to PDD. Limitations include heterogeneity of cross-sectional effect sizes and the potential impact of small-study effects. Areas for continued research include visuospatial skills and visual memory in PD-MCI and longitudinal examination of executive dysfunction in PD-MCI.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cognition; Dementia; Mild cognitive impairment; Parkinson’s disease

Mesh:

Year:  2021        PMID: 33860906     DOI: 10.1007/s11065-021-09502-7

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  69 in total

1.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

2.  Memory impairment in Parkinson's disease: The retrieval versus associative deficit hypothesis revisited and reconciled.

Authors:  Ondrej Bezdicek; Tommaso Ballarini; Herman Buschke; Filip Růžička; Jan Roth; Franziska Albrecht; Evžen Růžička; Karsten Mueller; Matthias L Schroeter; Robert Jech
Journal:  Neuropsychology       Date:  2019-03       Impact factor: 3.295

Review 3.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

4.  Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?

Authors:  Jane E Alty; Jeremy Cosgrove; Stuart Jamieson; Stephen L Smith; Katherine L Possin
Journal:  Clin Neurol Neurosurg       Date:  2015-10-17       Impact factor: 1.876

5.  Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Authors:  D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

6.  Mild cognitive impairment disrupts attention network connectivity in Parkinson's disease: A combined multimodal MRI and meta-analytical study.

Authors:  Ondrej Bezdicek; Tommaso Ballarini; Filip Růžička; Jan Roth; Karsten Mueller; Robert Jech; Matthias L Schroeter
Journal:  Neuropsychologia       Date:  2018-03-11       Impact factor: 3.139

7.  Cognitive impairment and resting-state network connectivity in Parkinson's disease.

Authors:  Hugo-Cesar Baggio; Bàrbara Segura; Roser Sala-Llonch; Maria-José Marti; Francesc Valldeoriola; Yaroslau Compta; Eduardo Tolosa; Carme Junqué
Journal:  Hum Brain Mapp       Date:  2014-08-28       Impact factor: 5.038

8.  Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.

Authors:  Federica Agosta; Elisa Canu; Elka Stefanova; Lidia Sarro; Aleksandra Tomić; Vladana Špica; Giancarlo Comi; Vladimir S Kostić; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2013-07-11       Impact factor: 5.038

9.  Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.

Authors:  Roberta Baschi; Alessandra Nicoletti; Vincenzo Restivo; Deborah Recca; Mario Zappia; Roberto Monastero
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.

Authors:  Rizwan S Akhtar; Sharon X Xie; Yin J Chen; Jacqueline Rick; Rachel G Gross; Ilya M Nasrallah; Vivianna M Van Deerlin; John Q Trojanowski; Alice S Chen-Plotkin; Howard I Hurtig; Andrew D Siderowf; Jacob G Dubroff; Daniel Weintraub
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

View more
  1 in total

Review 1.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.